Ignite Creation Date:
2024-10-25 @ 8:00 PM
Last Modification Date:
2024-10-26 @ 3:37 PM
Study NCT ID:
NCT06543069
Status:
RECRUITING
Last Update Posted:
None
First Post:
2024-08-03
Brief Title:
Sintilimab Bevacizumab Pemetrexed and Cisplatin for Unresectable MPeM
Sponsor:
Organization:
None